SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-16-108563
Filing Date
2016-06-16
Accepted
2016-06-16 16:57:25
Documents
5
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A v442262_pre14a.htm PRE 14A 345223
2 GRAPHIC tlogo.jpg GRAPHIC 9855
3 GRAPHIC tsig.jpg GRAPHIC 4001
4 GRAPHIC proxycard_001.jpg GRAPHIC 350432
5 GRAPHIC proxycard_002.jpg GRAPHIC 113438
  Complete submission text file 0001144204-16-108563.txt   998286
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 161718107
SIC: 2836 Biological Products, (No Diagnostic Substances)